Sign in
CompletedNo phase

The Effectiveness of CPII for Infertility Induced by PCOS in China

Key facts

Who runs it
Universiti Sains Malaysia
Where
China4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
192 people enrolled
Started
11 May 2025
Ended
11 May 2026
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Standard Treatment for PCOS-Induced Infertility
  • Counselling-Integrated Standard Care for PCOS-Induced Infertility
  • Personalized Care-Integrated Intervention (PII)
  • Integrated Counselling & Personalized Care for PCOS-Induced Infertility
Record updated
30 October 2026

Who can take part

Age
18 years to 45 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Women of reproductive age with PCOS-induced infertility in the four above-mentioned hospitals, with the following inclusion, exclusion, and withdrawal criteria:
  • Confirmed PCOS diagnosis by a physician per Rotterdam standards (antral follicle count (AFC) ≥12, or ovarian volume ≥10 ml; latest update raises AFC threshold to 20 follicles); significant metabolic risks include higher incidence of abnormal blood glucose and metabolic syndrome (Kim et al., 2020)
  • Documented infertility (failure to conceive after 12 months of regular attempts)
  • Aged 18-45 years (PCOS is most common in this group, where women are in a crucial pregnancy-planning stage with important physical and psychological development; extreme ages may cause greater fertility differences)

Who cannot take part

  • Prior specific infertility treatments (e.g., in vitro fertilization (IVF), ovulation induction)
  • Taking non-PCOS-related medications (hormonal treatments, hypoglycemic, antihypertensive, anti-anxiety, or antidepressant drugs); Withdrawal Criteria:
  • Other infertility causes (fallopian tube obstruction, male factor infertility), severe comorbidities, or systemic diseases
  • Severe or uncontrolled systemic diseases (cardiovascular, renal, liver diseases, or uncontrolled diabetes)
  • Gynecological conditions (endometriosis, untreated thyroid disorders, or significant hormonal imbalances)
  • Severe psychiatric disorders or cognitive impairments
  • Ineligibility or failure to meet criteria
  • Obesity or underweight
  • Simultaneous participation in other clinical trials/studies
  • Current pregnancy
  • Non-compliance with treatment protocol
  • Serious adverse effects or health risks
  • Personal reasons or inability to continue
  • Pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and is associated with metabolic, reproductive and mental health complications. Its prevalence has been reported to be between 5% and 15% in different studies, showcasing its significant impact on the reproductive health of Chinese women. A holistic approach to PCOS treatment that integrates physical, emotional, and mental health is lacking in China. The integration of counseling and personalized care into existing healthcare frameworks may have economic implications on patients with PCOS-induced infertility.

Read full original descriptionShow less

This study aimed to compare the effectiveness of the counselling, personalized care, and counseling-personalized care-integrated interventions versus the current module on the clinical outcomes over six months among patients of PCOS-induced infertility. The primary outcomes are menstrual cycle, hormonal parameters, metabolic parameters, and biochemical pregnancy. The secondary outcomes include anxiety and depression, sleep quality, and patient satisfaction. This study also explored the perceived challenges and barriers among patients with PCOS-induced infertility and healthcare providers involved in counseling-personalized care-integrated interventions in China.

The mixed-method sequential interpretative design was applied. The quantitative component involved a non-randomized controlled trial. A total of 192 patients were recruited by convenient sampling from reproductive medicine centers of four hospitals in Shandong Province. One hospital implemented each module. Data has been collected through a review of medical records and questionnaires. Descriptive statistical and repeated measure analysis of variance has been applied using SPSS version 28.0. The qualitative component involved the phenomenological approach of in-depth interviews of patients and healthcare providers involved in the counseling-personalized care-integrated interventions. Approximately 36 respondents were invited for online interviews via purposive sampling. A thematic analysis has been performed using Nvivo version 14.

The 4 groups in the trial

  • Standard Treatment Intervention (STI)Existing treatment, for comparison

    Participants receive standard clinical treatment for PCOS-induced infertility following Chinese clinical guidelines. Interventions include lifestyle management, routine medication guidance, laparoscopic ovarian puncture (for eligible patients), and traditional Chinese medicine care (acupuncture, cupping, moxibustion). No additional psychological counselling or personalized care is provided.

    Treatment: Standard Treatment for PCOS-Induced Infertility

  • Counselling-Integrated Intervention Arm for PCOS-Induced InfertilityTreatment being tested

    This arm is based on the standard treatment (same as STI arm) and adds structured psychological counseling. Interventions include cathartic therapy, cognitive behavioral reconstruction, relaxation training, and positive reinforcement for patients with elevated SAS/SDS scores, provided by professional mental health personnel.

    Treatment: Standard Treatment for PCOS-Induced Infertility and Counselling-Integrated Standard Care for PCOS-Induced Infertility

  • Personalized Care-Integrated Intervention (PII)Treatment being tested

    Participants receive the same standard treatment as the STI group plus individualized personalized care, including tailored diet plans, exercise prescription and regular follow-up.

    Treatment: Standard Treatment for PCOS-Induced Infertility and Personalized Care-Integrated Intervention (PII)

  • Counseling and personalized care-integrated intervention (CPII)Treatment being tested

    Participants receive the same standard treatment as the STI group, combined with both psychological counselling and individualized personalized care.

    Treatment: Standard Treatment for PCOS-Induced Infertility and Integrated Counselling & Personalized Care for PCOS-Induced Infertility

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effectiveness of Counselling and Personalized Care-Integrated Interventions for Infertility Induced by Polycystic Ovary Syndrome in China
Record updated
30 October 2026